pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-155 |
Genomic Coordinates | chr21: 25573980 - 25574044 |
Description | Homo sapiens miR-155 stem-loop |
Comment | Human mir-155 is predicted based on homology to a cloned miR from mouse (MIR:MI0000177) . |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
Mature miRNA Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-155-3p | ||||||||||||||||||
Sequence | 43| CUCCUACAUAUUAGCAUUAACA |64 | ||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||
Experiments | Cloned | ||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Biomarker Information |
|
---|
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | ADAMTS5 | ||||||||||||||||||||
Synonyms | ADAM-TS 11, ADAM-TS 5, ADAM-TS5, ADAMTS-11, ADAMTS-5, ADAMTS11, ADMP-2 | ||||||||||||||||||||
Description | ADAM metallopeptidase with thrombospondin type 1 motif 5 | ||||||||||||||||||||
Transcript | NM_007038 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on ADAMTS5 | |||||||||||||||||||||
3'UTR of ADAMTS5 (miRNA target sites are highlighted) |
>ADAMTS5|NM_007038|3'UTR 1 CCTGTGGTTATGATCTTATGCACAAAGATAACTGGAGGATTCAGCACTGATGCAGTCGTGGTGAACAGGAGGTCTACCTA 81 ACGCACAGAAAGTCATGCTTCAGTGACATTGTCAACAGGAGTCCAATTATGGGCAGAATCTGCTCTCTGTGACCAAAAGA 161 GGATGTGCACTGCTTCACGTGACAGTGGTGACCTTGCAATATAGAAAAACTTGGGAGTTATTGAACATCCCCTGGGCTTA 241 CAAGAAACACTGATGAATGTAAAATCAGGGGACATTTGAAGATGGCAGAACTGTCTCCCCCTTGTCACCTACCTCTGATA 321 GAATGTCTTTAATGGTATCATAATCATTTTCACCCATAATACACAGTAGCTTCTTCTTACTGTTTGTAAATACATTCTCC 401 CTTGGTATGTCACTTTATATCCCCTGGTTCTATTAAAATATCCATATATATTTCTATAAAAAAAGTGTTTGACCAAAGTA 481 GGTCTGCAGCTATTTCAACTTCCTTCCGTTTCCAGAAAGAGCTGTGGATATTTTACTGGAAATTAAGAACTTGCTGCTGT 561 TTTAATAAGATGTAGTATATTTTCTGACTACAGGAGATAAAATTTCAGTCAAAAAACCATTTTGACAGCAAGTATCTTCT 641 GAGAAATTTTGAAAAGTAAATAGATCTCAGTGTATCTAGTCACTTAAATACATACACGGGTTCATTTACTTAAACCTTTG 721 ACTGCCTGTATTTTTTTCAGGTAGCTAGCCAAATTAATGCATAATTTCAGATGTAGAAGTAGGGTTTGCGTGTGTGTGTG 801 TGATCATACTCAAGAGTCTAAAAACTAGTTTCCTTGTGTTGGAAATTTAAAAGGAAAAAAATCGTATTTCACTGTGTTTT 881 CAATTTATATTTTCACAACTACTTTCTCTCTCCAGAGCTTTCATCTGATATCTCACAATGTATGATATACGTACAAAACA 961 CACAGCAAGTTTTCTATCATGTCCAACACATTCAACACTGGTATACCTCCTACCAGCAAGCCTTTAAAATGCATTTGTGT 1041 TTGCTTATTTGTTTTGTTCAAGGGTTCAGTAAGACCTACAATGTTTTGTATTTCTTGACTTATTTTATTAGAAACATTAA 1121 AGATCACTTGGTAGTTAGCCACATTGAGAAGTGGTTATCATTGTTAATGTGGTTAATGCCAAAAAGTGGTTAATATTAAT 1201 AAGACTGTTTCCACACCATAGGCAATAATTTCTTAATTTAAAAAATCTAAGTATATTCCTATTGTACTAAATATTTTTCC 1281 CAACTGGAAAGCACTTGATTGTACCCGTAAGTGTTTGAGTGATGACATGTGATGATTTTCAGAAAGTTGTTGTTTTTGTT 1361 TCCATAGCCTGTTTAAGTAGGTTGTAAGTTTGAATAGTTAGACATGGAAATTATTTTATAAGCACACACCTAAAGATATC 1441 TTTTTAGATGATAAAATGTACACCCCCCCATCACCAACCTCACAACTTAGAAAATCTAAGTTGTTTGATTTCTTTGGGAT 1521 TTCTTTTGTTGTGAAACACTGCAAAGCCAATTTTTCTTTATAAAAATTCATAGTAATCCTGCCAAATGTGCCTATTGTTA 1601 AAGATTTGCATGTGAAGATCTTAGGGAACCACTGTTTGAGTTCTACAAGCTCATGAGAGTTTATTTTTATTATAAGATGT 1681 TTTTAATATAAAAGAATTATGTAACTGATCACTATATTACATCATTTCAGTGGGCCAGGAAAATAGATGTCTTGCTGTTT 1761 TCAGTATTTTCTTAAGAAATTGCTTTTAAAACAAATAATTGTTTTACAAAACCAATAATTATCCTTTGAATTTTCATAGA 1841 CTGACTTTGCTTTTGACGTAGAAATTTTTTTTCTCAATAAATTATCACTTTGAGAAATGAGGCCTGTACAAGGCTGATAA 1921 CCTATATGTGATGGAGATCACCCAATGCCAAGGGCAGAAAGCAAACCTAGTTAAATAGGTGAGAAAAAAAATAATAATCC 2001 CAGTGCCATTTGTCTGTGCAAAGAGAATTAGGAGAGAGGTTAATGTTACTTTTTTCCATTTTGGAAATAATTTTAATCAA 2081 GTAACTCAAATGTGACAAAATTTATTTTTATTTTTTGTGGTTATATTCCCAACAACATTAAAAAATACTCGAGGCATAAA 2161 TGTAGTTGTCTCCTACTCTGCTTCTCTTACTATACTCATACATTTTTAATATGGTTTATCAATGATTCATGTTTCCCTCA 2241 AATAGTGATGGTTTACACCTGTCATGGAAACAATCCTAGAGAGCTCAGAGCAATTAAACCACTATTCCATGCTTTTAAGT 2321 AGTTTTCTCCACCTTTTTCTTATGAGTCTCACTAGATTGACTGAGGAATGTATGTCTAAATTCCTGGAGAAGATGATATG 2401 GATTGGAAACTGAAATTCAGAGAAATGGAGTGTTCAATAGATACCACGAATTGTGAACAAAGGGAAAATTCTATACAACT 2481 CAATCTAAGTCAGTCCACTTTGACTTCGTACTGTCTTTCACCTTTCCATTGTTGCATCTTGAATTTTTTAAAATGTCTAG 2561 AATTCAGGATGCTAGGGGCTACTTCTTTAAAAAAAAAAAAAAAAAAGAATTCGTCTGAAAATGCTCAGGTTTGTAAGAAT 2641 CTAATCTCACTTACATAACTAAGCACTCCATAATAAGTTTTATTAAGTACAAAGGGAGCCAGAAAAAATGACATTTATTT 2721 CTTCTAGATCAGAAAAATTTAAATTAAGCCCTGCCTTGCTGTTTAGAAATATGTGGGCATTGTTATAATTTATTCAATAA 2801 ATTTATGTTCCTTTGCCTTCCTGTGGAAACAGTTTTATCCCACTAAACTAGGAATTAGGGGATAAATCACAAACAAAAAA 2881 AAAGTTGCAGCACTGAAAAAAAGTAATTTATTGTTTTTGCAACTGGTATGTGAATTTGTGTGATAAAATTATTTATTCTT 2961 ATTTAACAAAAATATGTTCAAATTTTTCTATATTTAAAATGTTTTGCTGTTGTCCTACTTTTTAATTTATGCTTCATGTT 3041 TGTGTATAAAGTACACTTTTACACTTTGTGAGTTTACATAATATACAGCACTGGTTGCTTTTGTATTTTTTTACAGAAAG 3121 CTTTCTGTGTGAAGCAGGTGTATATGTATATATTCCTCATGTATTCTTATTCTGATACTATCATTTTTCTTTCCAAGGAA 3201 ATTTTAATCTGTCATGACCAATAGTGTTCATTACTTGTGCCTATGATAATAGGTTTTTTACATCACATTAACACTATTTT 3281 TTCCAAGTCACAAATAAGAAAAACACTTATTCAATGAAACAAGGTGCAAGTTTTAAATTTGGGTACACAAATAGCCTAGA 3361 AGCTTCCTACAGACGCTAAGACACAGCCAATAATCAGATCCTTTCACTTCATCGAGAAACTTGGACAAGTCGATATTGAT 3441 GTATTAGATGAAAGTTGTCTACACACAACTTCTGAGGGATACAAACGATAATAAAACCAAATGTTGTCTGTTTCTCCTTT 3521 AGAAACACCTCCTAAAATTAATATCATTTAGTCTCTAGTGTCTGTAGGATTCTACAGATGAGCACAAATAGATTGGGTTT 3601 GTATAACAAATGCTAATAGTCATAACTGTTTCTACAAATATGGGGTGTCCATTAAGAGAATGTGATGTTTTCCTACTGCT 3681 GTTGAATCCCATGGGGTGATTATAGGACTTGAAATAGGCAGAGTCACCTCTGATGACATCAGCTTGCCTCTGTGATTTCA 3761 CAGTCTGATCCTGGCAACAAGACAAAGCACCCTTGGACACACAGCCAATCTCTGGTTGTGATATTTCCCCATTGATTCCT 3841 TCCTTGTTAACAAGGTCATTTTAATGGTTCAGGTGAGGACAGCAGCCAGATTCAAAGTCCAGAATTTGTGCTGTTACATA 3921 GAGTTCACACTGTCAAATAACATTGAATTTAATAATGATCAAATTTTTCTAGTAGTCTTTGGCAGAGTGTATAATCTCAT 4001 TGGCATGATTGGTGAATATTACTAATCTCTTTATAATGAAAGATGCTTTACAAATACCTTATATTTGCTAACATTTCAAA 4081 ACTACTAAATAAATGAAATAGCCATGTGTACAGAAATGGTCATTTAAAGCTTTAATAGAACCAAATTCAAGACAATGTAT 4161 CATTTAGACACACAGAAAAGGAACTTGTATGTTTTCCCTATTATTTTTCTCATTTGCCAACAATCTATAGTTTTAGGTTA 4241 TCAAACAGATAGATCAACTTAACTGGCTAGTACATTGAAAAATCTTCCTAAGAATCCTTTGTTAGCATAATCTATAGAGA 4321 TAATTTCTCAAATTATATCATCATGATGCATATAAACTCTATAATGTATAATTGTGTTTCATTTATTTAATGTATGAGAA 4401 CATATTGAAATACAAAACCATGCATTAGCCAAAAAATTGGAATACAGGTAGTGTTCAGATCAGCAAAACATTCAGTCTGG 4481 TAAATGCCTGCCTGGGGCTATGATATCATTCTCAATGCAGGTTTTATGGAAAAACTAAAAGAATATGTTGTTAGATGATG 4561 TTGGTTTTGAAAAAAAAAAGACATTAACATACACATTAGTTAGCCCAGTTAATTGCATTCTACTAATATAGTTGCACATT 4641 AGCAATAATTTTGCTGTCTCTGGTCTTTATTTTGTGGCTTCAACTAACTGGACCATGTGGACTGTAAAGGTCAAATGGAA 4721 AAAACGAGCAGTGGCCCCTCATCCTGTAAGGTACTGCTACATCAGAGTGACCTAAAAGTCTAACACTGTGAGGAAAACTG 4801 TGATTTGTAGGAAAAAAAAAAAAAACAAATAAAAAACAGGGCATGCTTTTTAATTTTTTTCCACTTTCCTTTGGCACACC 4881 CAATGAACAATTCTAATTTTTATTGAGGTGCTAACATCTTTCGTGACCGACTGTCAAATGTGGTATTTTTGAGTTACTAT 4961 TTTTCTACATGATTTTACAGTTTGCAAGAAAGACCTCTAAGCTTTGTGTCACGGTAGGGCACAACTTGATACTCAAAATT 5041 TGAAAAATAAGCACATCCAATGATTGTTTTGACCAACAGTGGTCAGTGACGTAAACTGCATGTGCATCTGAGGACATTTA 5121 AGGGGTCATTAAAATTTGAGGAGCATCAGGCCGGAGTAGCAGACTTTTAGATGAGTCATATTTCAGCATTCACTAAGTCC 5201 TCAGCATTCCATTCAAACTGTCGTGTATATTTGGCCTGATTTTTTTTCAAGCTTTGCAATAATTTATGTTATTGGTAAAC 5281 ACTTGGTGACTATATCTCAGCCTTTTCTTTAACAACTCACAATATATTAGAAACACGTCTACCTATACTGAGAGTATATT 5361 TACAATAGAAGAACATACTGTATGTGACTTTGTAAAGCTAGACTTTTGATTAAGAAATATATAATCTCTGGATGCTATTT 5441 TTGCATTATACACTCAGGCACAACGTAAACCTTGATGGCTCATCTTGCTACAATTACGAGTTGAAAAACACTACTTACGT 5521 ATTTGTATGACCTATTAGTCAGAGGAAATCATACATATGCTTTGTAAATAGACTTTGCAGATAACTAAATAGACTGAAGA 5601 AATATGTTGCATTTGATAGAAGCAATTGCATAAATATTTGGTTTCTATATTAGAGTCTGTGAGTAAAGTCAAGTAATAAA 5681 CCTAAGTAGGTATAACAGATTTTTAAACCTTGAAACTTGCTTTGATGGTAGAGAAAATCATTGAAGATTTACATACTGTA 5761 TATAAGATGTAAAATGTACGCTGCTTATTACCCTCAATTTTCCAGAAGCAATGGTATATAATGCAGTTGAAAAACCAAAA 5841 ATCTTGGAAAACTAAGACGGGTCTTGTTTAAAATGTCTCTCAGCTTTGGCAACCTTCAAATCTTAATCAACTATTTAAAG 5921 CATTACTGTGTCTTGTAGCCTGCATTCCACAACAGCTCTGTTATTCAGGTAAAAGACTTGAACTGAGCCGTTTGGGACCT 6001 ATACTGTAATATTTTCATTGAGGAACAATATCCTATTTTGTAAAGCATTTCCCTATGTGTGACTTTAAACTGTAAAATTA 6081 AACACTGCTTTTGTGGGTTCAGTGGGCATAATAAATATAAATTGTAAACTAGGTTAAAGTAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HeLa | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in Chi_124A_2A8_130_50. RNA binding protein: AGO. Condition:HeLa cell miR-124 + A
HITS-CLIP data was present in Chi_124B_2A8_130_50. RNA binding protein: AGO. Condition:HeLa cell miR-124 + B
... - Chi SW; Zang JB; Mele A; Darnell RB, 2009, Nature. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Chi SW; Zang JB; Mele A; Darnell RB - Nature, 2009
MicroRNAs (miRNAs) have critical roles in the regulation of gene expression; however, as miRNA activity requires base pairing with only 6-8 nucleotides of messenger RNA, predicting target mRNAs is a major challenge. Recently, high-throughput sequencing of RNAs isolated by crosslinking immunoprecipitation (HITS-CLIP) has identified functional protein-RNA interaction sites. Here we use HITS-CLIP to covalently crosslink native argonaute (Ago, also called Eif2c) protein-RNA complexes in mouse brain. This produced two simultaneous data sets-Ago-miRNA and Ago-mRNA binding sites-that were combined with bioinformatic analysis to identify interaction sites between miRNA and target mRNA. We validated genome-wide interaction maps for miR-124, and generated additional maps for the 20 most abundant miRNAs present in P13 mouse brain. Ago HITS-CLIP provides a general platform for exploring the specificity and range of miRNA action in vivo, and identifies precise sequences for targeting clinically relevant miRNA-mRNA interactions.
LinkOut: [PMID: 19536157]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293S |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1084064. RNA binding protein: AGO2. Condition:CLIP_noemetine_AbnovaAb
HITS-CLIP data was present in GSM1084065. RNA binding protein: AGO2. Condition:CLIP_emetine_AbnovaAb
HITS-CLIP data was present in GSM1084066. RNA binding protein: AGO2. Condition:CLIP_noemetine_SantaCruzAb
HITS-CLIP data was present in GSM1084067. RNA binding protein: AGO2. Condition:CLIP_emetine_SantaCruzAb
HITS-CLIP data was present in GSM1084068. RNA binding protein: AGO2. Condition:CLIP_noemetine_SigmaAb
HITS-CLIP data was present in GSM1084069. RNA binding protein: AGO2. Condition:CLIP_emetine_SigmaAb
HITS-CLIP data was present in GSM1084075. RNA binding protein: AGO2. Condition:CLIP_hippuristanol_rep1_SantaCruzAb
HITS-CLIP data was present in GSM1084078. RNA binding protein: AGO2. Condition:CLIP_nohippuristanol_rep2_AbnovaAb
HITS-CLIP data was present in GSM1084079. RNA binding protein: AGO2. Condition:CLIP_hippuristanol_rep2_AbnovaAb
HITS-CLIP data was present in GSM1084080. RNA binding protein: AGO2. Condition:CLIP_nohippuristanol_rep2_SantaCruzAb
HITS-CLIP data was present in GSM1084081. RNA binding protein: AGO2. Condition:CLIP_hippuristanol_rep2_SantaCruzAb
HITS-CLIP data was present in GSM1084082. RNA binding protein: AGO2. Condition:CLIP_nohippuristanol_rep2_SigmaAb
HITS-CLIP data was present in GSM1084083. RNA binding protein: AGO2. Condition:CLIP_hippuristanol_rep2_SigmaAb
... - Karginov FV; Hannon GJ, 2013, Genes & development. |
Article |
- Karginov FV; Hannon GJ - Genes & development, 2013
When adapting to environmental stress, cells attenuate and reprogram their translational output. In part, these altered translation profiles are established through changes in the interactions between RNA-binding proteins and mRNAs. The Argonaute 2 (Ago2)/microRNA (miRNA) machinery has been shown to participate in stress-induced translational up-regulation of a particular mRNA, CAT-1; however, a detailed, transcriptome-wide understanding of the involvement of Ago2 in the process has been lacking. Here, we profiled the overall changes in Ago2-mRNA interactions upon arsenite stress by cross-linking immunoprecipitation (CLIP) followed by high-throughput sequencing (CLIP-seq). Ago2 displayed a significant remodeling of its transcript occupancy, with the majority of 3' untranslated region (UTR) and coding sequence (CDS) sites exhibiting stronger interaction. Interestingly, target sites that were destined for release from Ago2 upon stress were depleted in miRNA complementarity signatures, suggesting an alternative mode of interaction. To compare the changes in Ago2-binding patterns across transcripts with changes in their translational states, we measured mRNA profiles on ribosome/polysome gradients by RNA sequencing (RNA-seq). Increased Ago2 occupancy correlated with stronger repression of translation for those mRNAs, as evidenced by a shift toward lighter gradient fractions upon stress, while release of Ago2 was associated with the limited number of transcripts that remained translated. Taken together, these data point to a role for Ago2 and the mammalian miRNAs in mediating the translational component of the stress response.
LinkOut: [PMID: 23824327]
|
CLIP-seq Support 1 for dataset Chi_124A_2A8_130_50 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | HeLa / HeLa cell miR-124 + A |
Location of target site | ENST00000284987.5 | 3UTR | GUAGGAAAAAAAAAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 19536157 / Chi_HITSCLIP |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset Chi_124B_2A8_130_50 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | HeLa / HeLa cell miR-124 + B |
Location of target site | ENST00000284987.5 | 3UTR | GUAGGAAAAAAAAAAAAAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 19536157 / Chi_HITSCLIP |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM1084064 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_noemetine_AbnovaAb |
Location of target site | ENST00000284987.5 | 3UTR | GUAGGAAAAAAAAAAAAAAC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM1084065 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_emetine_AbnovaAb |
Location of target site | ENST00000284987.5 | 3UTR | AAAACUGUGAUUUGUAGGAAAAAAAAAAAAAAC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM1084066 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_noemetine_SantaCruzAb |
Location of target site | ENST00000284987.5 | 3UTR | GUAGGAAAAAAAAAAAAAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM1084067 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_emetine_SantaCruzAb |
Location of target site | ENST00000284987.5 | 3UTR | UGUAGGAAAAAAAAAAAAAAC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM1084068 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_noemetine_SigmaAb |
Location of target site | ENST00000284987.5 | 3UTR | GUAGGAAAAAAAAAAAAAAC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 8 for dataset GSM1084069 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_emetine_SigmaAb |
Location of target site | ENST00000284987.5 | 3UTR | UGUAGGAAAAAAAAAAAAAAC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 9 for dataset GSM1084075 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_hippuristanol_rep1_SantaCruzAb |
Location of target site | ENST00000284987.5 | 3UTR | GUAGGAAAAAAAAAAAAAAC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 10 for dataset GSM1084078 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_nohippuristanol_rep2_AbnovaAb |
Location of target site | ENST00000284987.5 | 3UTR | GUAGGAAAAAAAAAAAAAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 11 for dataset GSM1084079 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_hippuristanol_rep2_AbnovaAb |
Location of target site | ENST00000284987.5 | 3UTR | GUAGGAAAAAAAAAAAAAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 12 for dataset GSM1084081 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_hippuristanol_rep2_SantaCruzAb |
Location of target site | ENST00000284987.5 | 3UTR | UGUAGGAAAAAAAAAAAAAAC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 13 for dataset GSM1084082 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_nohippuristanol_rep2_SigmaAb |
Location of target site | ENST00000284987.5 | 3UTR | GUAGGAAAAAAAAAAAAAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 14 for dataset GSM1084083 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_hippuristanol_rep2_SigmaAb |
Location of target site | ENST00000284987.5 | 3UTR | GUAGGAAAAAAAAAAAAAAC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
73 hsa-miR-155-3p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT005808 | IRAK3 | interleukin 1 receptor associated kinase 3 | ![]() |
![]() |
![]() |
![]() |
4 | 1 | ||||
MIRT082844 | ZNF460 | zinc finger protein 460 | ![]() |
![]() |
2 | 4 | ||||||
MIRT256047 | UBE2K | ubiquitin conjugating enzyme E2 K | ![]() |
![]() |
2 | 4 | ||||||
MIRT437787 | PTEN | phosphatase and tensin homolog | ![]() |
![]() |
2 | 1 | ||||||
MIRT456168 | ZDHHC6 | zinc finger DHHC-type containing 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT464916 | TXNIP | thioredoxin interacting protein | ![]() |
![]() |
2 | 4 | ||||||
MIRT475559 | HNRNPF | heterogeneous nuclear ribonucleoprotein F | ![]() |
![]() |
2 | 2 | ||||||
MIRT499608 | DNAJA1 | DnaJ heat shock protein family (Hsp40) member A1 | ![]() |
![]() |
2 | 8 | ||||||
MIRT504220 | MYO6 | myosin VI | ![]() |
![]() |
2 | 4 | ||||||
MIRT504256 | C1orf147 | chromosome 1 open reading frame 147 | ![]() |
![]() |
2 | 4 | ||||||
MIRT507642 | CREBRF | CREB3 regulatory factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT522858 | KIAA1551 | KIAA1551 | ![]() |
![]() |
2 | 2 | ||||||
MIRT527505 | MYD88 | myeloid differentiation primary response 88 | ![]() |
![]() |
![]() |
![]() |
![]() |
5 | 2 | |||
MIRT530713 | ORMDL3 | ORMDL sphingolipid biosynthesis regulator 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT532851 | ZNF699 | zinc finger protein 699 | ![]() |
![]() |
2 | 2 | ||||||
MIRT535952 | MIA3 | MIA family member 3, ER export factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT539041 | ATXN1L | ataxin 1 like | ![]() |
![]() |
2 | 4 | ||||||
MIRT556391 | LUC7L | LUC7 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT558617 | CNOT6L | CCR4-NOT transcription complex subunit 6 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT559869 | ATXN3 | ataxin 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT569208 | SHC3 | SHC adaptor protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT573122 | C18orf25 | chromosome 18 open reading frame 25 | ![]() |
![]() |
2 | 2 | ||||||
MIRT575076 | Ddit4 | DNA-damage-inducible transcript 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT607597 | ABCF3 | ATP binding cassette subfamily F member 3 | ![]() |
![]() |
2 | 6 | ||||||
MIRT609386 | PHEX | phosphate regulating endopeptidase homolog X-linked | ![]() |
![]() |
2 | 2 | ||||||
MIRT610550 | MDN1 | midasin AAA ATPase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT612390 | TCF7L2 | transcription factor 7 like 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT612910 | GTDC1 | glycosyltransferase like domain containing 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT613314 | ARL5C | ADP ribosylation factor like GTPase 5C | ![]() |
![]() |
2 | 2 | ||||||
MIRT613356 | ADAMTS5 | ADAM metallopeptidase with thrombospondin type 1 motif 5 | ![]() |
![]() |
2 | 4 | ||||||
MIRT613541 | CLMP | CXADR like membrane protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT617029 | SYT6 | synaptotagmin 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT618044 | MRVI1 | murine retrovirus integration site 1 homolog | ![]() |
![]() |
2 | 2 | ||||||
MIRT619307 | KIRREL | kirre like nephrin family adhesion molecule 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT623209 | MTFR1L | mitochondrial fission regulator 1 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT625448 | RANGAP1 | Ran GTPase activating protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT634551 | MACC1 | MACC1, MET transcriptional regulator | ![]() |
![]() |
2 | 2 | ||||||
MIRT640740 | EPB41 | erythrocyte membrane protein band 4.1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT640906 | RAB13 | RAB13, member RAS oncogene family | ![]() |
![]() |
2 | 2 | ||||||
MIRT644025 | ZNF792 | zinc finger protein 792 | ![]() |
![]() |
2 | 2 | ||||||
MIRT651489 | WT1 | Wilms tumor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT652037 | LINC00598 | long intergenic non-protein coding RNA 598 | ![]() |
![]() |
2 | 2 | ||||||
MIRT669093 | CDK6 | cyclin dependent kinase 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT696720 | WNT3 | Wnt family member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT698085 | TPM1 | tropomyosin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT703284 | GID4 | GID complex subunit 4 homolog | ![]() |
![]() |
2 | 2 | ||||||
MIRT707183 | ARHGEF33 | Rho guanine nucleotide exchange factor 33 | ![]() |
![]() |
2 | 2 | ||||||
MIRT710362 | CREB5 | cAMP responsive element binding protein 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT713501 | DCAF17 | DDB1 and CUL4 associated factor 17 | ![]() |
![]() |
2 | 2 | ||||||
MIRT717153 | LRRC3C | leucine rich repeat containing 3C | ![]() |
![]() |
2 | 2 | ||||||
MIRT719038 | ATP1A1 | ATPase Na+/K+ transporting subunit alpha 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT719489 | LSG1 | large 60S subunit nuclear export GTPase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT720284 | DPYSL3 | dihydropyrimidinase like 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT732474 | NLRP3 | NLR family pyrin domain containing 3 | ![]() |
![]() |
2 | 0 | ||||||
MIRT732620 | MS | multiple sclerosis | ![]() |
1 | 0 | |||||||
MIRT732968 | TGFBR2 | transforming growth factor beta receptor 2 | ![]() |
![]() |
![]() |
3 | 0 | |||||
MIRT733063 | AGTR1 | angiotensin II receptor type 1 | ![]() |
![]() |
![]() |
3 | 0 | |||||
MIRT733206 | ADAM10 | ADAM metallopeptidase domain 10 | ![]() |
1 | 0 | |||||||
MIRT733302 | CRP | C-reactive protein | ![]() |
![]() |
2 | 0 | ||||||
MIRT734202 | PDCD4 | programmed cell death 4 | ![]() |
![]() |
![]() |
3 | 0 | |||||
MIRT734467 | SIRT1 | sirtuin 1 | ![]() |
![]() |
2 | 0 | ||||||
MIRT734701 | Foxo3 | forkhead box O3 | ![]() |
1 | 0 | |||||||
MIRT734889 | SP4 | Sp4 transcription factor | ![]() |
![]() |
2 | 0 | ||||||
MIRT735047 | BATF | basic leucine zipper ATF-like transcription factor | ![]() |
1 | 0 | |||||||
MIRT735048 | SPI1 | Spi-1 proto-oncogene | ![]() |
1 | 0 | |||||||
MIRT735734 | PICALM | phosphatidylinositol binding clathrin assembly protein | ![]() |
![]() |
![]() |
3 | 0 | |||||
MIRT735944 | TNF | tumor necrosis factor | ![]() |
1 | 0 | |||||||
MIRT736131 | MYLK | myosin light chain kinase | ![]() |
![]() |
2 | 0 | ||||||
MIRT736780 | FOXP3 | forkhead box P3 | ![]() |
1 | 0 | |||||||
MIRT736781 | CEBPB | CCAAT/enhancer binding protein beta | ![]() |
1 | 0 | |||||||
MIRT736858 | WEE1 | WEE1 G2 checkpoint kinase | ![]() |
![]() |
2 | 0 | ||||||
MIRT736873 | TLR3 | toll like receptor 3 | ![]() |
![]() |
2 | 0 | ||||||
MIRT736902 | CFH | complement factor H | ![]() |
![]() |
2 | 0 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|